Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00104
|
|||||
| Drug Name |
Tolbutamide
|
|||||
| Synonyms |
1-Butyl-3-(4-methylphenylsulfonyl)urea; 1-Butyl-3-(p-methylphenylsulfonyl)urea; 1-Butyl-3-(p-tolylsulfonyl)urea; 1-Butyl-3-(para-tolylsulfonyl) urea; 1-Butyl-3-tosylurea; 1-butyl-3-(4-methylphenyl)sulfonylurea; 1-p-Toluenesulfonyl-3-butylurea; 3-(p-Tolyl-4-sulfonyl)-1-butylurea; 3-(p-tolylsulfonyl)-1-butylurea; 3-[p-Tolyl-4-sulfonyl]-1-butylurea; Aglicid; Apo-Tolbutamide; Apotex Brand of Tolbutamide; Arcosal; Arkozal; Artosin; Artozin; Aventis Brand of Tolbutamide; Beglucin; Berlin-Chemie Brand of Tolbutamide; BerlinChemie Brand of Tolbutamide; Butamid; Butamide; Butamide Brand of Tolbutamide; Butamidum; D 860; Diaben; Diabesan; Diabetamid; Diabetol; Diabuton; Diasulfon; Diaval; Dirastan; Dolipol; Drabet; Glyconon; HLS 831; Hoechst Brand of Tolbutamide; Ipoglicone; Mobenol; N-(4-Methylbenzenesulfonyl)-N'-butylurea; N-(4-Methylphenylsulfonyl)-N'-butylurea; N-(p-Tolylsulfonyl)-N'-butylcarbamide; N-(p-tolylsulfonyl)-N'-n-butylurea; N-4-(Methylbenzolsulfonyl)-n-butylurea; N-4-Methylbenzolsulfonyl-N-butylurea; N-Butyl-N'-(4-methylphenylsulfonyl)urea; N-Butyl-N'-(p-tolylsulfonyl)urea; N-Butyl-N'-p-toluenesulfonylurea; N-Butyl-N'-toluene-p-sulfonylurea; N-n-Butyl-N'-tosylurea; Novo-Butamide; Orabet; Oralin; Oramide; Orezan; Orinase; Orinase (TN); Orinaz; Oterben; Pfizer Brand of Tolbutamide; Pramidex; R.A.N. Brand of Tolbutamide; Rastinon; Restinon; Sk-tolbutamide; T 0891; TOLBUTAMIDE USP; Tarasina; Tol-Tab; Tolbet;Tolbusal; Tolbutamid; Tolbutamid R.A.N.; Tolbutamida; Tolbutamida [INN-Spanish]; Tolbutamide (JP15/USP/INN); Tolbutamide Aventis Brand; Tolbutamide Butamide Brand; Tolbutamide Hoechst Brand; Tolbutamide Pfizer Brand; Tolbutamide [INN:BAN:JAN]; Tolbutamidum; Tolbutamidum [INN-Latin]; Tolbutone; Toluina; Tolumid; Toluran; Toluvan; Tolylsulfonylbutylurea; U 2043; Valdecasas Brand of Tolbutamide; Willbutamide; Yamanouchi Brand of Tolbutamide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Non insulin dependent diabetes [ICD11: 5A11] | Approved | [1] | |||
| Therapeutic Class |
Hypoglycemic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C12H18N2O3S
|
|||||
| Canonical SMILES |
CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
|
|||||
| InChI |
InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)
|
|||||
| InChIKey |
JLRGJRBPOGGCBT-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 64-77-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 270.35 | Topological Polar Surface Area | 83.6 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.3
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321470
, 10531694
, 11111857
, 11111858
, 11120087
, 11120575
, 11121063
, 11121572
, 11122052
, 11147170
, 11335516
, 11360755
, 11362641
, 11363341
, 11364689
, 11365203
, 11365903
, 11367251
, 11367765
, 11368465
, 11369813
, 11370553
, 11370554
, 11371678
, 11372854
, 11373366
, 11373934
, 11375413
, 11375927
, 11376627
, 11377976
, 11457019
, 11461727
, 11466218
, 11467338
, 11484736
, 11485776
, 11489026
, 11490415
, 11492173
, 5658513
, 640044
, 7847446
, 7980810
, 8144417
, 8149557
, 8153385
, 855782
, 85591
, 9357
|
|||||
| ChEBI ID |
ChEBI:27999
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SUR1 | Transporter Info | Sulfonylurea receptor 1 | Substrate | [2] | |
| SUR2 | Transporter Info | Sulfonylurea receptor 2 | Substrate | [2] | ||
| References | ||||||
| 1 | Tolbutamide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch. 2007 Feb;453(5):703-18. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.